Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors
Recruiting · NCT05639933 · Registry updated 2026-03-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors | Infections, Skin and Connective Tissue Diseases, nail disorder, paronychia, skin disorder, skin disorder caused by infection | Recruiting | Phase 2 | 2026-03-31 | NCT05639933 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoth Therapeutics, Inc. | 1 |
| ICON Clinical Research | 8 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centrum Medyczne Pratia Krakow | Krakow | Poland | 1 |
| Dana Farber Cancer Institute | Boston | United States | 300 |
| Gabrail Cancer & Research Center | Canton | United States | 6 |
| Hospital Sant Joan de Deu-Fundacio Althaia | Manresa | Spain | 1 |
| MD Anderson Cancer Center | Houston | United States | 589 |
| Montefiore Medical Center | The Bronx | United States | 198 |
| Northwell Physician Partners Dermatology | New Hyde Park | United States | 1 |
| NYU Langone Health | Mineola | United States | 6 |
| NZOZ Neuromed M. i M. Nastaj Sp.P | Lublin | Poland | 4 |
| Regis Clinical Research | Miami | United States | 3 |
| UC Irvine - Chao Family Cancer Center | Orange | United States | 1 |
| UCI Health - CIACC | Irvine | United States | 1 |